CIBC World Market
PRME icon

CIBC World Market’s Prime Medicine PRME Stock Holding History

CIBC World Market’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-14,326
Closed -$35.4K – 1467
2025
Q2 		$35.4K Sell
14,326
-2,689
-16% -$4.14K ﹤0.01% 1339
2025
Q1 		$33.9K Sell
17,015
-2,008
-11% -$5.12K ﹤0.01% 1337
2024
Q4 		$56K Buy
19,023
+8,801
+86% +$30.9K ﹤0.01% 1332
2024
Q3 		$40K Sell
10,222
-1,113
-10% -$5.16K ﹤0.01% 1282
2024
Q2 		$58K Sell
11,335
-712
-6% -$4.32K ﹤0.01% 1233
2024
Q1 		$84K Sell
12,047
-214
-2% -$1.62K ﹤0.01% 1256
2023
Q4 		$109K Buy
+12,261
New +$94.5K ﹤0.01% 1200

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

CIBC World Market's PRME Position: Q3 2025 in Review

CIBC World Market sold out of Prime Medicine (PRME) in Q3 2025, closing a stake of 14,326 shares — an estimated $35.4K sold.

CIBC World Market first reported a position in PRME in Q4 2023 and held it in 7 quarters. The position peaked at $109K in Q4 2023. 167 funds tracked by Wall St. Rank hold PRME as of Q3 2025.

  • CIBC World Market reported no remaining Prime Medicine position as of Q3 2025 after selling out during the quarter.
  • CIBC World Market sold 14,326 Prime Medicine shares in Q3 2025, an estimated $35.4K.
  • CIBC World Market first reported a position in Prime Medicine in Q4 2023 and held it in 7 quarters.
  • CIBC World Market's Prime Medicine position peaked at $109K in Q4 2023.
  • 167 funds tracked by Wall St. Rank held Prime Medicine as of Q3 2025.

Based on CIBC World Market's 13F filing for Q3 2025, filed 6 Nov 2025.